AMY CHEUNG: Open Payments
NPI 1790919389 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 17 payments from 7 companies in 2025. Trend: 2023 $16 · 2024 $236 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 4 | $217 |
| Abbott Laboratories | 8 | $150 |
| Boston Scientific Corporation | 1 | $35 |
| Baxter Healthcare | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $15 |
Products named: Barostim Neo System, CARDIOMEMS, WATCHMAN FLX, Hillrom - Cardiac Ambulatory Monitor, AMVUTTRA, OPSUMIT, Wegovy, THORATEC HEARTMATE 3 LVAS IMPLANT KIT.
Industry payments across CA — which companies pay providers there.
